451 related articles for article (PubMed ID: 33002740)
1. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.
Satış H; Özger HS; Aysert Yıldız P; Hızel K; Gulbahar Ö; Erbaş G; Aygencel G; Guzel Tunccan O; Öztürk MA; Dizbay M; Tufan A
Cytokine; 2021 Jan; 137():155302. PubMed ID: 33002740
[TBL] [Abstract][Full Text] [Related]
2. High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19.
Guirao JJ; Cabrera CM; Jiménez N; Rincón L; Urra JM
Mol Immunol; 2020 Dec; 128():64-68. PubMed ID: 33075636
[TBL] [Abstract][Full Text] [Related]
3. Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19.
Xu Y; Wang N; Shen X; Liu X; Liu H; Liu Y
Clin Exp Med; 2023 Nov; 23(7):3719-3728. PubMed ID: 37310657
[TBL] [Abstract][Full Text] [Related]
4. Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020.
Sun H; Guo P; Zhang L; Wang F
Med Sci Monit; 2020 Nov; 26():e926941. PubMed ID: 33175722
[TBL] [Abstract][Full Text] [Related]
5. The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.
Copaescu A; James F; Mouhtouris E; Vogrin S; Smibert OC; Gordon CL; Drewett G; Holmes NE; Trubiano JA
Front Immunol; 2021; 12():646095. PubMed ID: 33815405
[TBL] [Abstract][Full Text] [Related]
6. IL-6 and other biomarkers as predictors of severity in COVID-19.
Broman N; Rantasärkkä K; Feuth T; Valtonen M; Waris M; Hohenthal U; Rintala E; Karlsson A; Marttila H; Peltola V; Vuorinen T; Oksi J
Ann Med; 2021 Dec; 53(1):410-412. PubMed ID: 33305624
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
[TBL] [Abstract][Full Text] [Related]
9. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
[TBL] [Abstract][Full Text] [Related]
10. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
11. Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients.
Phan F; Boussouar S; Lucidarme O; Zarai M; Salem JE; Kachenoura N; Bouazizi K; Charpentier E; Niati Y; Bekkaoui H; Amoura Z; Mathian A; Benveniste O; Cacoub P; Allenbach Y; Saadoun D; Lacorte JM; Fourati S; Laroche S; Hartemann A; Bourron O; Andreelli F; Redheuil A;
Cardiovasc Diabetol; 2021 Aug; 20(1):165. PubMed ID: 34384426
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.
Deng F; Zhang L; Lyu L; Lu Z; Gao D; Ma X; Guo Y; Wang R; Gong S; Jiang W
Med Clin (Barc); 2021 Apr; 156(7):324-331. PubMed ID: 33422296
[TBL] [Abstract][Full Text] [Related]
14. A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19).
Karampoor S; Zahednasab H; Farahmand M; Mirzaei R; Zamani F; Tabibzadeh A; Bouzari B; Ajdarkosh H; Nikkhah M; Hashemi MR; Laali A; Keyvani H
Int Immunopharmacol; 2021 Aug; 97():107684. PubMed ID: 33932696
[TBL] [Abstract][Full Text] [Related]
15. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
16. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
[No Abstract] [Full Text] [Related]
17. Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients.
Mortaz E; Tabarsi P; Jamaati H; Dalil Roofchayee N; Dezfuli NK; Hashemian SM; Moniri A; Marjani M; Malekmohammad M; Mansouri D; Varahram M; Folkerts G; Adcock IM
Front Immunol; 2021; 12():592727. PubMed ID: 33968010
[TBL] [Abstract][Full Text] [Related]
18. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
[TBL] [Abstract][Full Text] [Related]
19. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
Front Immunol; 2021; 12():668725. PubMed ID: 34276659
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infection.
Smith M; Lara OD; O'Cearbhaill R; Knisely A; McEachron J; Gabor L; Carr C; Blank S; Prasad-Hayes M; Frey M; Jee J; Fehniger J; Wang Y; Lee YC; Isani S; Wright JD; Pothuri B
Gynecol Oncol; 2020 Dec; 159(3):618-622. PubMed ID: 33019984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
